Waiting on $ILMN to recross 50EMA on the daily.

١١ يوليو ٢٠٢٢

Most biotechs are set to rally into 2023 following suppression and release of XBI through institutional channels. Components inside of XBI that initially contributed to its rise and gains over the years will be the source to start the process again.